1,123
Views
8
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: CANCER REHABILITATION

Assessing the utilization of the decision to implement a palliative goal for the treatment of cancer patients during the last year of life at Helsinki University Hospital: a historic cohort study

ORCID Icon, , , , , , , & show all
Pages 1699-1705 | Received 16 Apr 2019, Accepted 15 Aug 2019, Published online: 06 Sep 2019

References

  • Riley GF, Lubitz JD. Long-term trends in Medicare payments in the last year of life. Health Serv Res. 2010;45:565–576.
  • Earle CC, Neville BA, Landrum MB, et al. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol. 2004;22:315–321.
  • Ho TH, Barbera L, Saskin R, et al. Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol. 2011;29:1587–1591.
  • Earle CC, Neville BA, Landrum MB, et al. Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care. 2005;17:505–509.
  • Jones JA, Lutz ST, Chow E, et al. Palliative radiotherapy at the end of life: a critical review. CA Cancer J Clin. 2014;64:296–310.
  • Asola R, Huhtala H, Holli K. Intensity of diagnostic and treatment activities during the end of life of patients with advanced breast cancer. Breast Cancer Res Treat. 2006;100:77–82.
  • Braga S, Miranda A, Fonseca R, et al. The aggressiveness of cancer care in the last three months of life: a retrospective single centre analysis. Psychooncology. 2007;16:863–868.
  • Kao S, Shafiq J, Vardy J, et al. Use of chemotherapy at end of life in oncology patients. Ann Oncol. 2009;20:1555–1559.
  • Näppa U, Lindqvist O, Rasmussen BH, et al. Palliative chemotherapy during the last month of life. Ann Oncol. 2011;22:2375–2380.
  • Greer JA, Pirl WF, Jackson VA, et al. Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol. 2012;30:394–400.
  • Numico G, Trogu A, Cristofano A, et al. Active treatment given in the last weeks of life: poor quality cancer care or justifiable behavior?. Support Care Cancer. 2014;22:2813–2819.
  • Adam H, Hug S, Bosshard G. Chemotherapy near the end of life: a retrospective single-centre analysis of patients' charts. BMC Palliat Care. 2014;13:26.
  • Lee HS, Chun KH, Moon D, et al. Trends in receiving chemotherapy for advanced cancer patients at the end of life. BMC Palliat Care. 2015;14:4.
  • Pacetti P, Paganini G, Orlandi M, et al. Chemotherapy in the last 30 days of life of advanced cancer patients. Support Care Cancer. 2015;23:3277–3280.
  • Anshushaug M, Gynnild MA, Kaasa S, et al. Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway. Acta Oncol. 2015;54:395–402.
  • Rautakorpi LK, Seyednasrollah F, Mäkelä JM, et al. End-of-life chemotherapy use at a Finnish university hospital: a retrospective cohort study. Acta Oncol. 2017;56:1272–1276.
  • Matter-Walstra KW, Achermann R, Rapold R, et al. Cancer-related therapies at the end of life in hospitalized cancer patients from four Swiss cantons: SAKK 89/09. Oncology. 2015;88:18–27.
  • Guadagnolo BA, Liao KP, Elting L, et al. Use of radiation therapy in the last 30 days of life among a large population-based cohort of elderly patients in the United States. J Clin Oncol. 2013;31:80–87.
  • Huang J, Wai ES, Lau F, et al. Palliative radiotherapy utilization for cancer patients at end of life in British Columbia: retrospective cohort study. BMC Palliat Care. 2014;13:49.
  • Murphy JD, Nelson LM, Chang DT, et al. Patterns of care in palliative radiotherapy: a population-based study. J Oncol Pract. 2013;9:e220–e227.
  • Lavergne MR, Johnston GM, Gao J, et al. Variation in the use of palliative radiotherapy at end of life: examining demographic, clinical, health service, and geographic factors in a population-based study. Palliat Med. 2011;25:101–110.
  • Rautakorpi LK, Mäkelä JM, Seyednasrollah F, et al. Assessing the utilization of radiotherapy near end of life at a Finnish University Hospital: a restrospective cohort study. Acta Oncol. 2017;56:1265–1271.
  • Kumar P, Temel JS. End-of-life care discussions in patients with advanced cancer. J Clin Oncol. 2013;31:3315–3319.
  • Kowalski LP, Carvalho AL. Natural history of untreated head and neck cancer. Eur J Cancer. 2000;36:1032–1037.
  • Ledeboer QC, van der Schroeff MP, Pruyn JF, et al. Survival of patients with palliative head and neck cancer. Head Neck. 2011;33:1021–1026.
  • Heinonen T, Loimu V, Saarilahti K, et al. End-of-life pathway of head and neck cancer patients: single-institution experience. Eur Arch Otorhinolaryngol. 2018;275:545–551.
  • Hui D, Mori M, Watanabe SM, et al. Referral criteria for outpatient specialty palliative cancer care: an international consensus. Lancet Oncol. 2016;17:552–559.
  • Prigerson HG, Bao Y, Shah MA, et al. Chemotherapy use, performance status, and quality of life at the end of life. JAMA Oncol. 2015;1:778–784.
  • Meeuse JJ, van der Linden YM, van Tienhoven G, et al. Efficacy of radiotherapy for painful bone metastases during the last 12 week of life. Cancer. 2010;116:2716–2725.
  • Westhoff PG, de Graeff A, Monninkhof EM, et al. Quality of life in relation to pain response to radiation therapy for painful bone metastases. Int J Radiat Oncol Biol Phys. 2015;93:694–701.
  • Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363:733–742.
  • Bakitas M, Lyons KD, Hegel MT, et al. Effects of a palliative care interventions on clinical outcomes in patients with advanced cancer: the project ENABLE II randomized controlled trial. JAMA. 2009;302:741–749.
  • Zimmerman , et al. Early palliative care for patients with advanced cancer: a cluster-randomized controlled trial. Lancet. 2014;383:1721–1730.
  • Hirvonen OM, Alalahti JA, Syrjänen KJ, et al. End-of-life decisions guiding the palliative care of cancer patients visiting emergency department in South Western Finland; a retrospective cohort study. BMC Palliat Care. 2018;17:128.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.